{"id":459,"date":"2025-01-22T08:00:00","date_gmt":"2025-01-22T13:00:00","guid":{"rendered":"https:\/\/www.techsequences.org\/podcasts\/?p=459"},"modified":"2025-01-16T18:47:43","modified_gmt":"2025-01-16T23:47:43","slug":"the-productivity-paradox-can-ai-fix-pharmas-rd-crisis","status":"publish","type":"post","link":"https:\/\/www.techsequences.org\/podcasts\/2025\/01\/the-productivity-paradox-can-ai-fix-pharmas-rd-crisis\/","title":{"rendered":"The Productivity Paradox: Can AI Fix Pharma&#8217;s R&amp;D Crisis?"},"content":{"rendered":"\n<p>Despite a $145.5 billion investment in pharmaceutical R&amp;D in 2023, US Federal Drug Administration novel drug approvals remain stagnant at around 43 annually, according to recent findings from Deloitte&#8217;s 14th Annual Pharmaceutical Innovation Report. The complexity of modern diseases, combined with rising development costs and regulatory requirements, demands a fundamental transformation in how we approach pharmaceutical R&amp;D.\u00a0<\/p>\n\n\n\n<p>Join us for a discussion with Dr. Brendan Frey, Professor at the University of Toronto, Deep Genomics founder, and Vector Institute co-founder, to explore how AI and tech-sector approaches like open source collaboration and shared data platforms can reverse this productivity paradox.<\/p>\n\n\n\n<p><strong>Hosted by:<\/strong> Alexa Raad and Leslie Daigle.<\/p>\n\n\n\n<p><strong>Further reading:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.prnewswire.com\/news-releases\/deloittes-14th-annual-pharmaceutical-innovation-report-pharma-rd-return-on-investment-rebounds-after-record-low-302126552.html\">Deloitte&#8217;s 14th Annual Pharmaceutical Innovation Report: Pharma R&amp;D Return on Investment Rebounds After Record Low<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/themedicinemaker.com\/business-regulation\/why-pharma-must-embrace-ai-and-open-source\">Why Pharma Must Embrace AI and Open Source<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.mckinsey.com\/industries\/life-sciences\/our-insights\/accelerating-clinical-trials-to-improve-biopharma-r-and-d-productivity\">Accelerating clinical trials to improve biopharma R&amp;D productivity<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.theglobeandmail.com\/business\/article-artificial-intelligence-drug-research-hype\/\">Revolution, interrupted: Why AI has failed to live up to the hype in drug development<\/a><\/li>\n<\/ul>\n\n\n\n<p>The views and opinions expressed in this program are our own and may not reflect the views or positions of our employers.<\/p>\n<div class=\"powerpress_player\" id=\"powerpress_player_7917\"><audio class=\"wp-audio-shortcode\" id=\"audio-459-1\" preload=\"none\" style=\"width: 100%;\" controls=\"controls\"><source type=\"audio\/mpeg\" src=\"https:\/\/media.blubrry.com\/techsequences\/content.blubrry.com\/techsequences\/20250122-BrendanFrey.mp3?_=1\" \/><a href=\"https:\/\/media.blubrry.com\/techsequences\/content.blubrry.com\/techsequences\/20250122-BrendanFrey.mp3\">https:\/\/media.blubrry.com\/techsequences\/content.blubrry.com\/techsequences\/20250122-BrendanFrey.mp3<\/a><\/audio><\/div><p class=\"powerpress_links powerpress_links_mp3\" style=\"margin-bottom: 1px !important;\">Podcast: <a href=\"https:\/\/media.blubrry.com\/techsequences\/content.blubrry.com\/techsequences\/20250122-BrendanFrey.mp3\" class=\"powerpress_link_pinw\" target=\"_blank\" title=\"Play in new window\" onclick=\"return powerpress_pinw('https:\/\/www.techsequences.org\/podcasts\/?powerpress_pinw=459-podcast');\" rel=\"nofollow\">Play in new window<\/a> | <a href=\"https:\/\/media.blubrry.com\/techsequences\/content.blubrry.com\/techsequences\/20250122-BrendanFrey.mp3\" class=\"powerpress_link_d\" title=\"Download\" rel=\"nofollow\" download=\"20250122-BrendanFrey.mp3\">Download<\/a><\/p><p class=\"powerpress_links powerpress_subscribe_links\">Subscribe: <a href=\"https:\/\/podcasts.apple.com\/us\/podcast\/techsequences\/id1509826111?mt=2&amp;ls=1\" class=\"powerpress_link_subscribe powerpress_link_subscribe_itunes\" target=\"_blank\" title=\"Subscribe on Apple Podcasts\" rel=\"nofollow\">Apple Podcasts<\/a> | <a href=\"https:\/\/open.spotify.com\/show\/6BgXkvatS6UgsTsJVi7BJE?si=N7tlTeOkTlOrg3Ysco2nbw\" class=\"powerpress_link_subscribe powerpress_link_subscribe_spotify\" target=\"_blank\" title=\"Subscribe on Spotify\" rel=\"nofollow\">Spotify<\/a> | <a href=\"https:\/\/subscribeonandroid.com\/www.techsequences.org\/podcasts\/feed\/podcast\/\" class=\"powerpress_link_subscribe powerpress_link_subscribe_android\" target=\"_blank\" title=\"Subscribe on Android\" rel=\"nofollow\">Android<\/a> | <a href=\"https:\/\/www.techsequences.org\/podcasts\/feed\/podcast\/\" class=\"powerpress_link_subscribe powerpress_link_subscribe_rss\" target=\"_blank\" title=\"Subscribe via RSS\" rel=\"nofollow\">RSS<\/a><\/p><!--powerpress_player-->","protected":false},"excerpt":{"rendered":"<p>Despite a $145.5 billion investment in pharmaceutical R&amp;D in 2023, US Federal Drug Administration novel drug approvals remain stagnant at around 43 annually, according to recent findings from Deloitte&#8217;s 14th Annual Pharmaceutical Innovation Report. The complexity of modern diseases, combined<\/p>\n","protected":false},"author":2,"featured_media":461,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[44,45,42],"tags":[],"class_list":["post-459","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-44","category-ai-2","category-medical"],"jetpack_featured_media_url":"https:\/\/www.techsequences.org\/podcasts\/wp-content\/uploads\/2025\/01\/TS-PodcastHeaders.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.techsequences.org\/podcasts\/wp-json\/wp\/v2\/posts\/459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.techsequences.org\/podcasts\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.techsequences.org\/podcasts\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.techsequences.org\/podcasts\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.techsequences.org\/podcasts\/wp-json\/wp\/v2\/comments?post=459"}],"version-history":[{"count":1,"href":"https:\/\/www.techsequences.org\/podcasts\/wp-json\/wp\/v2\/posts\/459\/revisions"}],"predecessor-version":[{"id":460,"href":"https:\/\/www.techsequences.org\/podcasts\/wp-json\/wp\/v2\/posts\/459\/revisions\/460"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.techsequences.org\/podcasts\/wp-json\/wp\/v2\/media\/461"}],"wp:attachment":[{"href":"https:\/\/www.techsequences.org\/podcasts\/wp-json\/wp\/v2\/media?parent=459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.techsequences.org\/podcasts\/wp-json\/wp\/v2\/categories?post=459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.techsequences.org\/podcasts\/wp-json\/wp\/v2\/tags?post=459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}